Lentiviral short hairpin RNA screen of human kinases and phosphatases to identify potential biomarkers in oral squamous cancer cells

Oral carcinoma is a serious public health problem and the leading cause of head and neck cancer mortality worldwide. Moreover, oral cancer patients often present symptoms at a late stage and show a high recurrence rate after treatment. Therefore, there is an urgent need to identify novel biomarkers...

Full description

Saved in:
Bibliographic Details
Published inInternational journal of oncology Vol. 39; no. 5; pp. 1221 - 1231
Main Authors YEH, Ming-Han, TSAI, Tzung-Chieh, KUO, Han-Peng, CHANG, Nai-Wen, LEE, Miao-Rong, CHUNG, Jing-Gung, TSAI, Ming-Hsui, LIU, Jah-Yao, KAO, Ming-Ching
Format Journal Article
LanguageEnglish
Published Athens Editorial Academy of the International Journal of Oncology 01.11.2011
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Oral carcinoma is a serious public health problem and the leading cause of head and neck cancer mortality worldwide. Moreover, oral cancer patients often present symptoms at a late stage and show a high recurrence rate after treatment. Therefore, there is an urgent need to identify novel biomarkers for early diagnosis or clinical oral cancer therapy. In this study, we employed a subset of lentiviral short hairpin RNAs targeted against various kinases and phosphatases, designed by The RNAi Consortium, to screen systemically and in a high-throughput manner for potential growth regulators of oral cancer cells. The screen revealed a total of 50 candidate genes, for which more than 90% of growth inhibition in human oral squamous cancer HSC-3 cells was obtained. Furthermore, bioinformatic analysis of these candidate genes identified transforming growth factor-β receptor type II- and fms-related tyrosine kinase 3-related molecular pathways that are involved in NF-κB-mediated growth of HSC-3 cells. These candidate genes may be potential biomarkers for early diagnosis of oral cancer. In addition, these candidate genes represent potential targets for anticancer drug design helping to develop a personalized treatment to combat oral cancer.
ISSN:1019-6439
1791-2423
DOI:10.3892/ijo.2011.1100